University Hospital, Antwerp
Clinical trials sponsored by University Hospital, Antwerp, explained in plain language.
-
New Immune-Calming vaccine shows promise for progressive MS
Disease control Not yet recruitingThis early-phase trial tests a personalized cell therapy for people with progressive multiple sclerosis (MS). The treatment uses the patient's own immune cells, trained with vitamin D3 and myelin proteins, to calm the immune system and slow disability. The study will enroll 14 ad…
Phase: PHASE2 • Sponsor: University Hospital, Antwerp • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Smartwatch score aims to keep heart patients moving
Disease control Not yet recruitingThis study tests whether a special activity score, called the Antwerp Activity Index (AAI), can help people who have finished hospital-based cardiac rehab stay physically active. About 318 adults will wear a smartwatch for 4 months and do an exercise test at the end. Half will us…
Phase: NA • Sponsor: University Hospital, Antwerp • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
Sleep apnea study aims to uncover hidden heart dangers
Knowledge-focused Not yet recruitingThis study looks at 270 adults with moderate to severe sleep apnea to find better ways to measure heart risks. Researchers will test new tools that go beyond the usual breathing scores, like oxygen drops and heart rate changes during sleep. They will also see how different treatm…
Sponsor: University Hospital, Antwerp • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC